ALLO logo

Allogene Therapeutics (ALLO) Net Margin

Annual Net Margin

-344.49 K%
-126.28 K%-57.87%

31 December 2023

ALLO Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Margin

N/A

30 September 2024

ALLO Quarterly Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALLO Net Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-57.9%-
3 y3 years--
5 y5 years--

ALLO Net Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years<-9999.0%at low
5 y5 years<-9999.0%at low
alltimeall time<-9999.0%at low

Allogene Therapeutics Net Margin History

DateAnnualQuarterly
Mar 2024
-
-295.45 K%(-27.7%)
Dec 2023
-344.49 K%(+57.9%)
-408.47 K%(+44.3%)
Sept 2023
-
-283.12 K%(-21.4%)
June 2023
-
-360.15 K%(+8.1%)
Mar 2023
-
-333.23 K%(+96.4%)
Dec 2022
-218.21 K%
-
DateAnnualQuarterly
Sept 2022
-
-169.69 K%(+95.1%)
June 2022
-
-86.96 K%(-33.6%)
Mar 2022
-
-130.90 K%(<-9900.0%)
Dec 2021
-159.57%
0.11%(-100.0%)
Sept 2021
-
-159.56 K%(-1.0%)
June 2021
-
-161.22 K%(>+9900.0%)
Mar 2021
-
-86.10%

FAQ

  • What is Allogene Therapeutics annual net profit margin?
  • What is the all time high annual net margin for Allogene Therapeutics?
  • What is Allogene Therapeutics annual net margin year-on-year change?
  • What is the all time high quarterly net margin for Allogene Therapeutics?

What is Allogene Therapeutics annual net profit margin?

The current annual net margin of ALLO is -344.49 K%

What is the all time high annual net margin for Allogene Therapeutics?

Allogene Therapeutics all-time high annual net profit margin is -159.57%

What is Allogene Therapeutics annual net margin year-on-year change?

Over the past year, ALLO annual net profit margin has changed by -126.28 K% (-57.87%)

What is the all time high quarterly net margin for Allogene Therapeutics?

Allogene Therapeutics all-time high quarterly net profit margin is 0.11%